StockData
Zai Lab Ltd logo

Zai Lab Ltd (ZLAB) stock

ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30420% above fair value
$23.53+0.06 (+0.26%)

Close on Nov 17, 2026Market cap $3.65BP/E –Yield –

Zai Lab price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zai Lab's price to sales ratio was 6.6× on Nov 11, 2026, against 5.1× a year earlier. Over the last 5 years it ranged from 4.2× to 52.0×, with a median of 9.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.6×+2.2
2025Dec 31, 20254.4×−2.8
2024Dec 31, 20247.2×−2.8
2023Dec 29, 202310.1×−5.0
2022Dec 30, 202215.0×−37.0
2021Dec 31, 202152.0×−211.2
2020Dec 31, 2020263.2×–

More Zai Lab figures

See a number that looks wrong?